Zhenzhen Zhan

1.9k total citations
41 papers, 1.3k citations indexed

About

Zhenzhen Zhan is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Zhenzhen Zhan has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Immunology and 10 papers in Cancer Research. Recurrent topics in Zhenzhen Zhan's work include Cardiac Fibrosis and Remodeling (8 papers), Signaling Pathways in Disease (5 papers) and Immune Response and Inflammation (5 papers). Zhenzhen Zhan is often cited by papers focused on Cardiac Fibrosis and Remodeling (8 papers), Signaling Pathways in Disease (5 papers) and Immune Response and Inflammation (5 papers). Zhenzhen Zhan collaborates with scholars based in China, United States and Australia. Zhenzhen Zhan's co-authors include Xingguang Liu, Xuetao Cao, Feng Ma, Xu Dong Zhang, Hao Cao, Nan Li, Zhongmin Liu, Qingqing Zhou, Huimin Fan and Dong Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Zhenzhen Zhan

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenzhen Zhan China 17 658 507 394 216 118 41 1.3k
Youliang Wang China 20 696 1.1× 278 0.5× 327 0.8× 304 1.4× 232 2.0× 44 1.5k
Fei He China 18 766 1.2× 543 1.1× 276 0.7× 137 0.6× 211 1.8× 33 1.4k
Tiina Skoog Sweden 17 359 0.5× 360 0.7× 201 0.5× 225 1.0× 165 1.4× 27 1.1k
Coen van Solingen United States 21 1.3k 1.9× 552 1.1× 1.0k 2.6× 272 1.3× 86 0.7× 40 2.1k
Ghada Alsaleh France 22 824 1.3× 533 1.1× 463 1.2× 214 1.0× 191 1.6× 36 1.8k
Aimee Landry United States 10 609 0.9× 346 0.7× 170 0.4× 189 0.9× 149 1.3× 11 1.3k
Bongkun Choi South Korea 22 531 0.8× 346 0.7× 151 0.4× 196 0.9× 233 2.0× 43 1.2k
Marah C. Runtsch United States 14 1.4k 2.1× 707 1.4× 854 2.2× 151 0.7× 139 1.2× 22 2.1k
Ole Kristoffer Olstad Norway 24 1.1k 1.6× 274 0.5× 362 0.9× 155 0.7× 264 2.2× 103 1.9k
Chang Feng China 11 721 1.1× 239 0.5× 575 1.5× 166 0.8× 94 0.8× 16 1.2k

Countries citing papers authored by Zhenzhen Zhan

Since Specialization
Citations

This map shows the geographic impact of Zhenzhen Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenzhen Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenzhen Zhan more than expected).

Fields of papers citing papers by Zhenzhen Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenzhen Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenzhen Zhan. The network helps show where Zhenzhen Zhan may publish in the future.

Co-authorship network of co-authors of Zhenzhen Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenzhen Zhan. A scholar is included among the top collaborators of Zhenzhen Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenzhen Zhan. Zhenzhen Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Ying, Zhenzhen Zhan, Shunfen Zhang, et al.. (2025). Limosilactobacillus reuteri SXDT-32-derived shikimic acid protects against colonic inflammation in piglets by inhibiting the PI3K-Akt pathway. Journal of Animal Science and Biotechnology. 16(1). 84–84.
3.
Zhang, Yunkai, Xiaohui Wang, Xiang Yan, et al.. (2025). Phosphatase PHLPP1 is an alveolar-macrophage-intrinsic transcriptional checkpoint controlling pulmonary fibrosis. Cell Reports. 44(3). 115399–115399. 1 indexed citations
4.
Zhang, Sheng, et al.. (2024). Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism. Circulation. 149(25). 1982–2001. 35 indexed citations
5.
Yu, Huidi, Zhenzhen Zhan, Wei Liu, et al.. (2024). TRIF-TAK1 signaling suppresses caspase-8/3-mediated GSDMD/E activation and pyroptosis in influenza A virus-infected airway epithelial cells. iScience. 28(1). 111581–111581. 3 indexed citations
6.
Zhang, Yunkai, Yujia Wang, Xiang Yan, et al.. (2024). RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring. Cellular and Molecular Immunology. 21(11). 1231–1250. 12 indexed citations
7.
Tan, Yong, et al.. (2023). Murine neonatal cardiac B cells promote cardiomyocyte proliferation and heart regeneration. npj Regenerative Medicine. 8(1). 7–7. 19 indexed citations
8.
Hu, Meiling, et al.. (2023). IRG1 prevents excessive inflammatory responses and cardiac dysfunction after myocardial injury. Biochemical Pharmacology. 213. 115614–115614. 16 indexed citations
9.
Zhang, Yunkai, et al.. (2023). Targeting KAT2A inhibits inflammatory macrophage activation and rheumatoid arthritis through epigenetic and metabolic reprogramming. SHILAP Revista de lepidopterología. 4(3). e306–e306. 27 indexed citations
11.
Wang, Bo, Yong Tan, Yunkai Zhang, et al.. (2022). Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression. Experimental & Molecular Medicine. 54(12). 2175–2187. 24 indexed citations
12.
Tan, Yong, Shuaiyao Lu, Bo Wang, et al.. (2022). Single‐cell transcriptome atlas reveals protective characteristics of COVID‐19 mRNA vaccine. Journal of Medical Virology. 95(1). e28161–e28161. 6 indexed citations
13.
Tan, Yong, Tong Li, Meiling Hu, et al.. (2022). PHLPP1 deficiency ameliorates cardiomyocyte death and cardiac dysfunction through inhibiting Mcl-1 degradation. Cellular Signalling. 92. 110281–110281. 10 indexed citations
14.
Zhou, Qingqing, Yunkai Zhang, Bo Wang, et al.. (2019). KDM2B promotes IL-6 production and inflammatory responses through Brg1-mediated chromatin remodeling. Cellular and Molecular Immunology. 17(8). 834–842. 37 indexed citations
15.
Yang, Jing, Bo Wang, Na Li, et al.. (2019). Salvia miltiorrhizaandCarthamus tinctoriusExtract Prevents Cardiac Fibrosis and Dysfunction after Myocardial Infarction by Epigenetically Inhibiting Smad3 Expression. Evidence-based Complementary and Alternative Medicine. 2019. 1–12. 19 indexed citations
16.
Wang, Bo, Qingqing Zhou, Yiru Wang, et al.. (2018). MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7. Cell Death and Disease. 9(7). 769–769. 136 indexed citations
17.
Zhan, Zhenzhen, Min Sun, Yiming Jiang, Li Li, & Jin Li. (2016). Effect of Tin on The Corrosion Resistance of 16 Cr Ferritic Stainless Steel in Acidic Solution and Chloride-Containing Media. International Journal of Electrochemical Science. 11(5). 3963–3975. 1 indexed citations
18.
Fan, Huimin, et al.. (2015). GW26-e4725 MicroRNA-21 Regulates Post-Ischemic Inflammation Triggered by DAMPs in Myocardial Infarction Through Targeting STK40. Journal of the American College of Cardiology. 66(16). C25–C25. 1 indexed citations
19.
Zhan, Zhenzhen, Xuefeng Xie, Hao Cao, et al.. (2013). Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy. 10(2). 257–268. 176 indexed citations
20.
Zhan, Zhenzhen, Qun Li, Ping Wu, et al.. (2012). Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1. Autophagy. 8(1). 109–121. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026